Literature DB >> 35064867

Physicochemical Characterization and In Vitro Digestibility Study of an In Silico Designed Recombinant Protein Enriched with Large Neutral Amino Acids and Lacking Phenylalanine for Phenylketonuria.

Prakruthi Appaiah1,2, L Sunil1,2, Asha Martin1,2, Prasanna Vasu3,4.   

Abstract

In our previous study, a 3D structure of LNAA66 model protein containing 4-5 α-helices, high large neutral amino acids (LNAA) and lacking phenylalanine was designed, refined, expressed in Pichia pastoris and confirmed by Western blotting. Here the study is focused on the characterization of the expressed and purified recombinant LNAA66 protein. The results revealed that the expressed protein had 68.59% of LNAA enrichment, containing 41.6% of α-helix, 50.4% turns and 8% β-sheet, which are as per the in silico designed protein. The LC-ESI-MS/MS results confirmed the recombinant protein by identifying the first 30 N-terminal amino acids with a sequence coverage of ~ 29%. The protein was digested entirely into smaller molecular weight fragments when treated with digestive enzymes mimicking the human GI tract digestion, which indicated complete digestibility of the protein. These results suggest that the protein can be utilized for the envisioned application of dietary treatment for phenylketonuria.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CD spectroscopy; In vitro protein digestion; LC–ESI–MS/MS; LNAA66 protein

Mesh:

Substances:

Year:  2022        PMID: 35064867     DOI: 10.1007/s10930-021-10039-0

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  22 in total

1.  Using circular dichroism spectra to estimate protein secondary structure.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 2.  The application of circular dichroism to studies of protein folding and unfolding.

Authors:  S M Kelly; N C Price
Journal:  Biochim Biophys Acta       Date:  1997-04-04

3.  Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice.

Authors:  Danique van Vliet; Els van der Goot; Vibeke M Bruinenberg; Martijn van Faassen; Pim de Blaauw; Ido P Kema; M Rebecca Heiner-Fokkema; Eddy A van der Zee; Francjan J van Spronsen
Journal:  J Nutr Biochem       Date:  2017-10-12       Impact factor: 6.048

4.  Strategies Used in Production of Phenylalanine-Free Foods for PKU Management.

Authors:  Nafiseh Soltanizadeh; Leila Mirmoghtadaie
Journal:  Compr Rev Food Sci Food Saf       Date:  2014-05       Impact factor: 12.811

5.  Characterization of recombinant Trypanosoma brucei gambiense Translationally Controlled Tumor Protein (rTbgTCTP) and its interaction with Glossina midgut bacteria.

Authors:  Géraldine Bossard; Manon Bartoli; Marie-Laure Fardeau; Philippe Holzmuller; Bernard Ollivier; Anne Geiger
Journal:  Gut Microbes       Date:  2017-06-06

6.  Improvement, cloning, and expression of an in silico designed protein enriched with large neutral amino acids in Pichia pastoris for possible application in phenylketonuria.

Authors:  Prakruthi Appaiah; Prasanna Vasu
Journal:  J Food Biochem       Date:  2020-01-20       Impact factor: 2.720

7.  Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

Authors:  Adam M Belanger; Malgorzata Przybylska; Estelle Gefteas; Matthew Furgerson; Sarah Geller; Alla Kloss; Seng H Cheng; Yunxiang Zhu; Nelson S Yew
Journal:  JCI Insight       Date:  2018-07-26

8.  Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.

Authors:  Maria Giżewska; Anita MacDonald; Amaya Bélanger-Quintana; Alberto Burlina; Maureen Cleary; Turgay Coşkun; François Feillet; Ania C Muntau; Friedrich K Trefz; Francjan J van Spronsen; Nenad Blau
Journal:  Eur J Pediatr       Date:  2015-09-08       Impact factor: 3.183

9.  Propagation of Plasma L-Phenylalanine Concentration Fluctuations to the Neurovascular Unit in Phenylketonuria: An in silico Study.

Authors:  Mehdi Taslimifar; Stefano Buoso; Francois Verrey; Vartan Kurtcuoglu
Journal:  Front Physiol       Date:  2019-04-02       Impact factor: 4.566

10.  Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.

Authors:  Anita MacDonald; Rani H Singh; Júlio César Rocha; Francjan J van Spronsen
Journal:  Nutr Res Rev       Date:  2018-10-04       Impact factor: 7.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.